Live Cancer Patients updates

Live Cancer Patients news coverage of developments with the latest updates. Stay on top of latest Cancer Patients news stories and find out what just happened, what is going on with Cancer Patients. The latest real-time news updates and headlines on Cancer Patients
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
Planning Boost Frees 1500 Bed Nights in Hawke's Bay
New Uniforms Mark Milestone for Canberra Health Shift
EOI Opens for New Aged Care, Assisted Living Sites
Common Misconceptions About Exercise And Cancer
Amivantamab-Chemo Yields Best Survival in EGFR NSCLC
Zidesamtinib Shows 93% Response in ROS1-positive NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
Dr Tass Warns Peptide Enthusiasm Has Outpaced Evidence
Fatigue Often Missed as Liver Disease Signal
Parramatta Park Blooms: Iconic Flower Festival Begins
KAIST, KIOM Unveil Wearable Microneedle For Pain Relief
Research Finds Low Overdiagnosis In Breast Cancer Screening
Justin Gooding's Journey From Discovery To Impact
Polluted Air Linked to Increased Glaucoma, Cataract Risk
AI Tool Speeds Sepsis Detection on World Sepsis Day
Specialist Fee Crackdown Must Target More Than Outliers
Specialist Doctor Fee Crackdown Must Go Beyond Extreme Outliers
PBS Adds First Biologic for Uncontrolled COPD
Cancer Survival Up, But Legal and Financial Costs Rise
Smartphones May Screen for Cataracts, Eye Issues
Mullet Man Raises $4K+ for Aussie Prostate Cancer Aid
Centenarian Hosts Prostate Cancer Fundraiser at 100
New Chair Appointed for Australia Day Council
KAIST, KIOM Create Wearable Pain-Relief Device
4200km U.S. Trek Promotes Prostate Cancer Awareness
Bungendore Bowls Against Prostate Cancer for Mate
Works Start On North West Regional Hospital ED
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Ivonescimab Boosts Survival in PD-L1+ Advanced NSCLC
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
End Of Era For Andrew Luciani
NSW Sepsis Day Unveils New AI Tool for Faster Detection
Perception Test Predicts Laser Surgery Success
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Tarlatamab Dosing Shows Promise in Small Cell Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Subcutaneous Tarlatamab Safe, Effective in SCLC Trial
Diagnostics Target Hit, Waitlists Drop 21%
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
UNC Unveils Tool to Identify High-Risk Cancer Periods
CU Anschutz Advances Precision Medicine for Rare Cancers
Building Better CAR T-Cells For Cancer Treatment